0001140361-13-039588.txt : 20131025 0001140361-13-039588.hdr.sgml : 20131025 20131025154952 ACCESSION NUMBER: 0001140361-13-039588 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131025 DATE AS OF CHANGE: 20131025 EFFECTIVENESS DATE: 20131025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Altheus Therapeutics Inc CENTRAL INDEX KEY: 0001414163 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-174656 FILM NUMBER: 131170799 BUSINESS ADDRESS: STREET 1: 755 Research Parkway STREET 2: Suite 435 CITY: Oklahoma City STATE: OK ZIP: 73104 BUSINESS PHONE: (405) 319-8177 MAIL ADDRESS: STREET 1: 755 Research Parkway STREET 2: Suite 435 CITY: Oklahoma City STATE: OK ZIP: 73104 D/A 1 primary_doc.xml X0707 D/A LIVE 0001414163 Altheus Therapeutics Inc 755 RESEARCH PARKWAY SUITE 435 OKLAHOMA CITY OK OKLAHOMA 73104 (405) 319-8177 DELAWARE None None Corporation true Dennis Schafer 755 Research Parkway Suite 435 Oklahoma City OK OKLAHOMA 73104 Executive Officer Director Richard F. Harty, MD 755 Research Parkway Suite 435 Oklahoma City OK OKLAHOMA 73104 Executive Officer Brian L. Clevinger c/o Prolog Ventures, LLC 7733 Forsyth Blvd., Suite 1440 St. Louis MO MISSOURI 63105 Director William Paiva ONEOK Plaza 100 W. 5th St., Suite 705 Tulsa OK OKLAHOMA 74103 Director Thomas L. Shoaf Stifel Nicolaus Company, Inc. One Financial Plaza, 501 N. Broadway St. Louis MO MISSOURI 63102 Director Douglas A. Branch 101 N. Robinson Corporate Tower, 13th Floor Oklahoma City OK OKLAHOMA 73102 Director Dayton T. Reardan 755 Research Parkway Suite 435 Oklahoma City OK OKLAHOMA 73104 Executive Officer Biotechnology No Revenues 06b true 0001140361-13-001149 2012-02-24 true true true false 967 8195441 6850850 1344591 The total offering amount was amended 10/16/2013 to provide for the sale of up to an additional $2,344,590 of Series B shares and warrants in a series of three additional closings, the first of which closed 10/16/13 in the amount of $999,999. false 21 0 0 200000 true Includes legal fees paid to a law firm affiliated with a director of the Company and deferred payments owed to certain of the Company's executive officers and directors. false Altheus Therapeutics Inc Douglas A. Branch Douglas A. Branch Secretary 2013-10-25